Site-specific intravascular administration of drugs: History of a method applicable in humans

Catheterization and Cardiovascular Diagnosis

Volumn 41, Issue 3, 1997, Pages 342-347

  Camenzind, Edoardo ^a,b   Bakker, Willem H ^a   Reijs, Ambroos ^a   Van Geijlswijk, Ingeborg M ^a   Foley, David ^a   Krenning, Eric P ^a   Roelandt, Jos R T C ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Local drug delivery; Pharmacokinetics; Scintigraphy

Indexed keywords

ANGIOPEPTIN; FLUORESCEIN; HEPARIN; HIRUDIN; IODINE 125; MERTIATIDE TC 99M; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; TRITIUM;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; BLOOD VESSEL WALL; BOLUS INJECTION; CASE REPORT; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; FIBRINOLYTIC THERAPY; HEART SCINTISCANNING; HUMAN; INTRACORONARY INFUSION; INTRAVASCULAR CATHETER; ISOTOPE LABELING; MALE; NONHUMAN; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANEURYSM, DISSECTING; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTICOAGULANTS; CORONARY ANEURYSM; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; HEPARIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0030795962     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199707)41:3<342::AID-CCD16>3.0.CO;2-P     Document Type: Article

References (39)

1. Mabin TA, Holmes DR, Smith HC, Vlietstra RE, Bove AA, Reeder GS, Chesebro JH, Bresnahan JF, Orszulak TA: Intracoronary thrombus: Role in coronary occlusion compplicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 5:198-202, 1985.
2. Deligonul U, Gabliani GI, Caralis DG, Kern MJ, Vandormael MG: Percutaneous coronary angioplasty in patients with intracoronary thrombus. Am J Cardiol 62:474-476, 1988.
3. Mooney MR, Mooney JF, Goldenberg IF, Almquist AK, Van Tassel RA: Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi. Am J Cardiol 65:427-431, 1990.
4. Mitchel JF, Fram DB, Palmell DF, Foster R, Hirst JA, Azrin MA, Bow LM, Eldin AM, Waters DD, McKay RG: Enhanced intracoronary thrombolysis with urokinase using a novel local drug delivery system. In vitro, in vivo, and clinical studies. Circulation 91:785-793, 1995.
5. Azrin MA, Mitchel JF, Fram DB, Pedersen CA, Cartun RW, Barry JJ, Bow LM, Waters DD, McKay RG: Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons. Circulation 90:433-441, 1994.
6. Nunes GL, Hanson SR, King SB III, Sahatjian RA, Scott NA: Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J Am Coll Cardiol 23:1578-1583, 1994.
7. Nunes GL, Thomas CN, Hanson SR, Barry JJ, King SB, Scott NA: Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation 92:1697-1700, 1995.
8. Moura A, Lam JYT, Hebert D, Kermode JR, Grant GW, Robitaille D, Klein EJ, Yock PG, Simpson JB, Kaplan AV: Intramural delivery of agent via a novel drug-delivery sleeve: Histological and functional evaluation. Circulation 92:2299-2305, 1995.
9. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H: Restenosis after sucessful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12:616-623, 1988.
10. Serruys PW, Luijten HE, Beat KJ, Geuskens R, De Feyter PJ, Van Den Brand M, Reiber JHC, Ten Katen HJ, Van Es GA, Hugenholtz PG: Incidence of restenosis after successful coronary angioplasty: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 77:361-371, 1988.
11. Schwartz RS, Holmes DR, Topol EJ: The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 84:1426-1436, 1992.
12. Clowes AW, Reidy MA, Clowes MM: Mechanisms of stenosis after arterial injury. Lab Invest 49:208-215, 1983.
13. Clowes AW, Reidy MA, Clowes MM: Kinetics of cellular proliferation after arterial injury. I. Smooth muscle cell growth in the absence of endothelium. Lab Invest 49:327-333, 1983.
14. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF: Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 6:369-375, 1985.
15. Hermanns WRM, Rensing BJ, Strauss BH, Serruys PW: Methodological problems related to the quantitative assessment of stretch, elstic recoil and balloon-artery ratio. Cath Cardiovasc Diagn 25:174-185, 1992.
16. Isner JM: Vascular remodeling. Honey, I think I shrunk the artery. Circulation 89:2937-2941, 1994.
17. Herrman JPR, Hermans WRM, Vos J, Serruys P: Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the holy grail? (part I). Drugs 46:18-52, 1993.
18. Herrman JPR, Hermans WRM, Vos J, Serruys P: Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the holy grail? (part II). Drugs 46:249-262, 1993.
19. Wolinsky H, Thung SN: Local introduction of drugs into the arterial wall: A percutaneous catheter technique. J Intervent Cardiol 2:219-228, 1989.
20. Wolinsky H, Thung SN: Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 15:475-481, 1990.
21. Muller DWM, Topol EJ, Abrams GD, Gallagher KP, Ellis SG: Intramural methotrexate therapy for the prevention of neointimal thickening after ballon angioplasty. J Am Coll Cardiol 20:460-466, 1992.
22. Strauss BH, Wilson RA, van Houten R, van Suylen R-J, Murphy ES, Escaned J, Verdouw PD, Serruys PW, van der Giessen WJ: Late effects of locally delivered mitomycin C on formation of neointima and on vasomotor response to acetylcholine. Coron Artery Dis 5:633-644, 1994.
23. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ: Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 244:1342-1344, 1989.
24. Goldman B, Blanke H, Wolinsky H: Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase. A new catheter approach. Atherosclerosis 65:215-225, 1987.
25. Wolinsky H, Lin C-S: Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. J Am Coll Cardiol 17:174B-178B, 1991.
26. Hong MK, Bhatti T, Matthews BJ, Stark KS, Cathapermal SS, Foegh ML, Ramwell PW, Kent K: The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia afer balloon injury in the rabbit. Circulation 88:638-648, 1993.
27. Fram DB, Aretz T, Azrin MA, Mitchel JF, Samady H, Gillam LD, Sahajian R, Waters D, McKay RG: Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. J Am Coll Cardiol 23:1570-1577, 1994.
28. Fernandez-Ortiz A, Meyer BJ, Mailhac A, Chesebro JH, Badimon L, Hassinger N, Owen WG, Fuster V, Badimon JJ: Intravascular local delivery: An iontophoretic approach. Circulation 89:1518-1522, 1994.
29. Thomas CN, Robinson KA, Cipolla GD, Jones M, King SB III, Scott NA: In-vivo local delivery of heparin to coronary arteries with a microporous infusion catheter [abstract]. J Am Coll Cardiol 23:187 A, 1994.
30. Wilensky RL, March K, Gradus-Pizlo I, Schauwecker D, Michaels MB, Robinson J, Carlson K, Hataway DR: Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters. Am Heart J 129:852-859, 1995.
31. Camenzind E, Reys A, Ligthart J, Bakker W, van Geijlswijk I, Fioretti P, Krenning E, Serruys PW: Local intracoronary delivery of heparin and of a somatostatin analogue (octreotide) following angioplasty in man: Evaluation of efficacy of delivery by radioisotopic technique [abstract]. J Am Coll Cardiol 25:285-286, 1995.
32. Camenzind E, Bakker W, Reijs A, Geijlswijk van IM, Boersma E, Kutryk M, Krenning E, Roelandt JRTC, Serruys PW: Site-specific intracoronary heparin delivery in man after balloon angioplasty: A radioisotopic assessment of regional pharmacokinetics. Circulation (in press).
33. Simoons ML, Wijns W, Balakumaran K, Serruys PW, van den Brand M, Fioretti P, Reiber JH, Lie P, Hugenholtz PG: The effect of intracoronary thrombolysis with streptokinase on myocardial thallium distribution and left ventricular function assessed by blood-pool scintigraphy. Eur Heart J 3:433-440, 1982.
34. Camenzind E, Kint P-P, di Mario C, Ligthart J, van der Giessen W, Boersma E, Serruys PW: Intracoronary heparin delivery in man: Acute feasibility and longterm result. Circulation 92:2463-2472, 1995.
35. Kulkarni PV, Parkey RW, Buja LM, Wilson JE III, Bonte FJ, Willerson JT: Technetium-labeled heparin: Preliminary report of a new radiopharmaceutical with potential for imaging damaged coronary arteries and myocardium. J Nucl Med 19:810-815, 1978.
36. Camenzind E, Bakker W, Reijs A, van Geijlswijk I, Boersma E, Kutryk M, Krenning E, Roelandt J, Serruys P: Evaluation of efficiency of local intracoronary drug delivery following angioplasty in human: A radio-isotopic technique [abstract]. Eur Heart J 17:370, 1996.
37. Camenzind E, Reijs A, Bakker W, van Geijlswijk I, de Feyter P, Ruygrok P, Krenning E: Scintigraphic evaluation of efficacy of high pressure versus low pressure local heparin delivery in man after balloon angioplasty [abstract]. Circulation 92:I-725, 1995.
38. Camenzind E, Schaar M, Bakker W, Reijs A, Foley D, van der Giessen W, Krenning E: Scintigraphic comparison of local delivery efficiency of two delivery catheters (Dispatch versus Channel balloon) following balloon angioplasty in human [abstract]. Circulation, 94:I-201, 1996.
39. Camenzind E, Reijs A, Bakker W, Schaar M, van Geijlswijk I, Boersma E, Foley D, Krenning E, Serruys P: Evaluation of efficiency of local intracoronary drug delivery pre-stenting versus post-stenting using a new drug delivery device (Channel balloon) in human [abstract]. Circulation, 94:I-202, 1996.